Strong performance in Aerospace & Defense propels sequential growthQ2 2024 sales of $1.1 billion, up 5% from Q1 2024Q2 2024 net income attributable to ATI of $81.9 million, or $0.58 per share, up 26% from Q1 2024Aerospace & defense represent 62% of Q2 2024 sales, up from 59% of Q1 2024 salesNon-GAAP Information*Q2 adjusted net income attributable to ATI of $86.0 million or $0.60 per shareQ2 2024 ATI adjusted EBITDA of $182.6 million, or 16.7% of salesDALLAS, Aug. 6, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) ...

The most recent trading session ended with Allegheny Technologies (ATI) standing at $64.86, reflecting a -1.04% shift from the previouse trading day's closing. This move lagged the S&P 500's daily gain of 0.08%. Meanwhile, the Dow lost 0.12%, and the Nasdaq, a tech-heavy index, added 0.07%.Shares of the maker of steel and specialty metals have appreciated by 18.2% over the course of the past month, outperforming the Basic Materials sector's loss of 1.43% and the S&P 500's loss of 0.21%.Market participants w ...

Allegheny Technologies (ATI) closed at $65.54 in the latest trading session, marking a +1.96% move from the prior day. The stock's change was more than the S&P 500's daily gain of 1.11%. Meanwhile, the Dow experienced a rise of 1.64%, and the technology-dominated Nasdaq saw an increase of 1.03%.The the stock of maker of steel and specialty metals has risen by 13.73% in the past month, leading the Basic Materials sector's loss of 2.29% and the S&P 500's loss of 1.16%.The upcoming earnings release of Alleghen ...

BOLINGBROOK, Ill., July 26, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. – ("ATI" or the "Company") (NYSE: ATIP), a nationally recognized outpatient physical therapy provider in the United States, today announced that it will release second quarter 2024 financial results on Monday, August 5, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 5 p.m. ET on the same day.Conference Call DetailsManagement will host a conference call at 5 p.m. Eastern Ti ...

$2.2 billion to be delivered by 2030 FARNBOROUGH, England, July 23, 2024 /PRNewswire/ -- At the Farnborough International Airshow, ATI Inc. (NYSE: ATI) is celebrating its aerospace leadership by announcing $4 billion in new sales commitments through 2040. The majority of the additional revenue – approximately $2.2 billion – will be delivered in the balance of this decade. The collective commitments are predominantly for nickel alloys serving the jet engine market where ATI's high-performance materials and s ...

In the latest market close, Allegheny Technologies (ATI) reached $59.06, with a -1.2% movement compared to the previous day. This change lagged the S&P 500's daily loss of 0.78%. Meanwhile, the Dow lost 1.29%, and the Nasdaq, a tech-heavy index, lost 0.7%.Heading into today, shares of the maker of steel and specialty metals had gained 8.3% over the past month, outpacing the Basic Materials sector's gain of 1.42% and the S&P 500's gain of 2.14% in that time.The upcoming earnings release of Allegheny Technolo ...

DALLAS, July 2, 2024 /PRNewswire/ -- ATI (NYSE: ATI) has scheduled the live webcast for its second quarter 2024 earnings conference call on Tuesday, August 6, 2024, at 7:30 a.m. CT (8:30 a.m. ET).  Second quarter 2024 results are scheduled to be published prior to the call at 6:30 a.m. CT (7:30 a.m. ET).The conference call will be broadcast, and accompanying presentation slides will be available, at ATImaterials.com. To access the broadcast, visit ATImaterials.com and select "Conference Call." Conference ca ...

Robert S. Wetherbee becomes Executive Chairman DALLAS, July 1, 2024 /PRNewswire/ -- Kimberly A. Fields today became President and CEO of ATI Inc. [NYSE: ATI]. In a planned leadership transition, she succeeds Robert S. "Bob" Wetherbee, who becomes Executive Chairman.Fields served as ATI's Chief Operating Officer since 2022, becoming President in July 2023. During Kim's tenure, ATI has grown as one integrated operation, sharpening its operational advantages, increasing capacity and capability for the extraord ...

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL launched and commercial sales ongoing Funding commitments from U.S. Air Force Academy intended to advance ATI-1701 toward an IND submission to the FDA Engaging regulatory authorities to align on ATI-1801 development plans  HALIFAX, Nova Scotia, June 25, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medic ...

Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ResearchAndMarkets.com's offering.The 7 major rheumatoid arthritis markets reached a value of US$ 27.5 billion in 2023. Looking forward, the 7MM are projected to reach US$ 33.8 billion by 2034, exhibiting a growth rate (CAGR) of 2.32% during 2023-2034. This report provides an exhaustive analysis of the rheumatoid arthri ...